Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy.


Journal

BMJ open diabetes research & care
ISSN: 2052-4897
Titre abrégé: BMJ Open Diabetes Res Care
Pays: England
ID NLM: 101641391

Informations de publication

Date de publication:
2019
Historique:
received: 27 06 2019
revised: 28 09 2019
accepted: 23 10 2019
entrez: 8 1 2020
pubmed: 8 1 2020
medline: 1 9 2020
Statut: epublish

Résumé

Activin A, an inflammatory mediator implicated in cellular senescence-induced adipose tissue dysfunction and profibrotic kidney injury, may become a new target for the treatment of diabetic kidney disease (DKD) and chronic kidney diseases. We tested the hypothesis that human DKD-related injury leads to upregulation of activin A in blood and urine and in a human kidney cell model. We further hypothesized that circulating activin A parallels kidney injury markers in DKD. In two adult diabetes cohorts and controls (Minnesota, USA; Galway, Ireland), the relationships between plasma (or urine) activin A, estimated glomerular filtration rate (eGFR) and DKD injury biomarkers were tested with logistic regression and correlation coefficients. Activin A, inflammatory, epithelial-mesenchymal-transition (EMT) and senescence markers were assayed in human kidney (HK-2) cells incubated in high glucose plus transforming growth factor-β1 or albumin. Plasma activin A levels were elevated in diabetes (n=206) compared with controls (n=76; 418.1 vs 259.3 pg/mL; p<0.001) and correlated inversely with eGFR (r Circulating activin A is increased in human DKD and correlates with reduced kidney function and kidney injury markers. DKD-injured human renal tubule cells develop a profibrotic and inflammatory phenotype with activin A upregulation. These findings underscore the role of inflammation and provide a basis for further exploration of activin A as a diagnostic marker and therapeutic target in DKD.

Identifiants

pubmed: 31908790
doi: 10.1136/bmjdrc-2019-000720
pii: bmjdrc-2019-000720
pmc: PMC6936543
doi:

Substances chimiques

Biomarkers 0
activin A 0
Activins 104625-48-1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e000720

Subventions

Organisme : NIDDK NIH HHS
ID : K23 DK114497
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK109134
Pays : United States
Organisme : NIDDK NIH HHS
ID : K08 DK118120
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000135
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM065841
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK100081
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK102325
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002377
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK120292
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Am J Physiol Renal Physiol. 2018 May 1;314(5):F753-F762
pubmed: 29187373
J Am Soc Nephrol. 2001 Aug;12(8):1685-95
pubmed: 11461941
Am J Kidney Dis. 2003 Dec;42(6):1200-11
pubmed: 14655192
J Am Soc Nephrol. 2003 Jun;14(6):1523-34
pubmed: 12761253
Nephrol Dial Transplant. 2005 Feb;20(2):319-28
pubmed: 15673690
J Am Soc Nephrol. 2016 Dec;27(12):3589-3599
pubmed: 27020852
Nat Med. 2018 Aug;24(8):1246-1256
pubmed: 29988130
Diabetes Res Clin Pract. 2017 Jun;128:40-50
pubmed: 28437734
J Clin Pharmacol. 2013 Nov;53(11):1121-30
pubmed: 23939631
Nat Med. 2015 Sep;21(9):998-1009
pubmed: 26236991
Redox Biol. 2018 May;15:170-181
pubmed: 29253812
Nat Med. 2009 Sep;15(9):1082-7
pubmed: 19718037
Nephrology (Carlton). 2009 Apr;14(3):311-20
pubmed: 19298640
Cell Metab. 2019 May 7;29(5):1045-1060.e10
pubmed: 30799288
Kidney Int. 1993 Jul;44(1):115-9
pubmed: 8355451
Kidney Int. 2018 Jan;93(1):147-158
pubmed: 28843411
J Clin Endocrinol Metab. 1996 Jun;81(6):2125-30
pubmed: 8964839
Am J Physiol Cell Physiol. 2015 Apr 15;308(8):C621-30
pubmed: 25567807
Cell Commun Signal. 2009 Jun 18;7:15
pubmed: 19538713
Mol Cell Biol. 2017 May 31;37(12):
pubmed: 28320873
Clin Chem Lab Med. 2019 Mar 26;57(4):510-520
pubmed: 30218600
Mayo Clin Proc Innov Qual Outcomes. 2017 Sep 01;1(2):150-160
pubmed: 30225411
Clin Chem. 2007 Apr;53(4):766-72
pubmed: 17332152
Diabetes. 2017 Oct;66(10):2691-2703
pubmed: 28747378
J Am Soc Nephrol. 2004 Jan;15(1):91-101
pubmed: 14694161
Am J Physiol Renal Physiol. 2017 Feb 1;312(2):F297-F304
pubmed: 27881396
Nat Med. 2017 Sep;23(9):1072-1079
pubmed: 28825716
Aging Cell. 2019 Jun;18(3):e12950
pubmed: 30907060
Nature. 1995 Mar 23;374(6520):354-6
pubmed: 7885473
Sci Rep. 2018 Mar 26;8(1):5176
pubmed: 29581558
EBioMedicine. 2019 Sep;47:446-456
pubmed: 31542391
Clin Nutr. 2019 Feb;38(1):341-347
pubmed: 29398341
Kidney Int. 2016 Apr;89(4):767-78
pubmed: 26924058
J Am Soc Nephrol. 2019 May;30(5):726-736
pubmed: 31000567
Diabetes Care. 2018 Sep;41(9):1947-1954
pubmed: 29980527
Exp Gerontol. 2018 Oct 1;111:197-202
pubmed: 30071284
Am J Physiol Renal Physiol. 2008 Nov;295(5):F1563-73
pubmed: 18768588
J Am Soc Nephrol. 2017 Sep;28(9):2786-2793
pubmed: 28476763
Am J Physiol Cell Physiol. 2010 Aug;299(2):C374-80
pubmed: 20505038
Curr Diab Rep. 2016 May;16(5):42
pubmed: 27007719
Kidney Int. 2016 Jun;89(6):1231-43
pubmed: 27165838
Kidney Int. 1994 Jan;45(1):48-57
pubmed: 8127021
Elife. 2015 Dec 19;4:e12997
pubmed: 26687007
Nat Med. 2019 May;25(5):805-813
pubmed: 31011203
J Am Soc Nephrol. 2012 Mar;23(3):507-15
pubmed: 22266663
Kidney Int. 2004 Feb;65(2):510-20
pubmed: 14717921
Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
pubmed: 11904577
Clin Biochem. 2007 Sep;40(13-14):1084-7
pubmed: 17624320
Mayo Clin Proc. 2012 Jun;87(6):561-70
pubmed: 22677076
Biomed Res Int. 2014;2014:376191
pubmed: 24883308
Ann Intern Med. 2013 Jun 4;158(11):825-30
pubmed: 23732715

Auteurs

Xiaohui Bian (X)

Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Department of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China.

Tomás P Griffin (TP)

Centre for Endocrinology, Diabetes and Metabolism, Saolta University Health Care Group, Galway University Hospitals, Galway, Ireland.
Regenerative Medicine Institute (REMEDI) at CÚRAM SFI Research Centre, School of Medicine, National University of Ireland Galway, Galway, Ireland.

Xiangyang Zhu (X)

Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Md Nahidul Islam (MN)

Regenerative Medicine Institute (REMEDI) at CÚRAM SFI Research Centre, School of Medicine, National University of Ireland Galway, Galway, Ireland.
Department of Clinical Biochemistry, Saolta University Health Care Group, Galway University Hospitals, Galway, Ireland.

Sabena M Conley (SM)

Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Alfonso Eirin (A)

Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Hui Tang (H)

Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Paula M O'Shea (PM)

Department of Clinical Biochemistry, Saolta University Health Care Group, Galway University Hospitals, Galway, Ireland.

Allyson K Palmer (AK)

Division of Community Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Rozalina G McCoy (RG)

Division of Community Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Division of Geriatric Medicine and Gerontology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Sandra M Herrmann (SM)

Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Ramila A Mehta (RA)

Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.

John R Woollard (JR)

Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Andrew D Rule (AD)

Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

James L Kirkland (JL)

Division of Community Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Division of Geriatric Medicine and Gerontology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota, USA.

Tamar Tchkonia (T)

Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, Minnesota, USA.

Stephen C Textor (SC)

Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Matthew D Griffin (MD)

Regenerative Medicine Institute (REMEDI) at CÚRAM SFI Research Centre, School of Medicine, National University of Ireland Galway, Galway, Ireland.
Department of Nephrology, Saolta University Health Care Group, Galway University Hospitals, Galway, Ireland.

Lilach O Lerman (LO)

Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

LaTonya J Hickson (LJ)

Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Division of Geriatric Medicine and Gerontology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH